← Leaderboards
Robert F Struck
Southern Research Institute
$1,662,879
Attributed
$1,662,879
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $229.6K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$9,855,146 · 3
By mechanism
P01$8,954,040 · 2
R01$901,106 · 1
Top collaborators
No co-investigators on record.
Most similar at Southern Research Institute
Same institution · by research overlap
- Gary A Piazza$25,461,125
- Robert C Reynolds$7,796,684
- Subramaniam Ananthan$10,843,209
- Ashish Kumar Pathak$11,459,907
- Robert Walter Buckheit$12,955,650
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionAntineoplasticsPyridineAnalogChemical Structure FunctionNeoplasm /Cancer PharmacologyNeoplasm /Cancer ChemotherapyCrosslinkLaboratory MouseDrug Screening /EvaluationTissue /Cell CultureNucleoside AnalogChemical SynthesisPharmacokineticsBiological ModelsBrain NeoplasmsLiver MetabolismNeoplasm /Cancer TransplantationCytotoxicityHigh Performance Liquid ChromatographyCyclophosphamideFree RadicalsAthymic MouseIntermolecular Interaction
Grant awards (11)
4-Peroxycyclophosphamides for Brain Tumor Therapy$217,702
R01 · FY2007 · CA · contact PI
4-Peroxycyclophosphamides for Brain Tumor Therapy$224,204
R01 · FY2006 · CA · contact PI
4-Peroxycyclophosphamides for Brain Tumor Therapy$229,600
R01 · FY2005 · CA
4-Peroxycyclophosphamides for Brain Tumor Therapy$229,600
R01 · FY2004 · CA
Development of New Antitumor Agents$2,158,301
P01 · FY2003 · CA
Development of New Antitumor Agents$2,095,999
P01 · FY2002 · CA
PENCLOMEDINE$228,401
P01 · FY2002 · CA
Development of New Antitumor Agents$2,034,948
P01 · FY2001 · CA
PENCLOMEDINE$228,401
P01 · FY2001 · CA
DEVELOPMENT OF NEW ANTITUMOR AGENTS$1,903,019
P01 · FY2000 · CA
PENCLOMEDINE$304,971
P01 · FY2000 · CA